Takeda Partners With U.S. University On Basic Cancer Antibody Research
This article was originally published in PharmAsia News
Executive SummaryTakeda Pharmaceutical says it has signed an agreement with the University of California, San Francisco to collaborate on ways to synthesize an antibody for cancer metastasis
You may also be interested in...
Genomic profiling firm Foundation Medicine hires new chief commercial officer; Bardy Diagnostics, developer of cardiac arrhythmia devices, picks a chief operating officer; Lantheus Medical Imaging, producer of diagnostic imaging agents and products; brings aboard a new chief medical officer; and more.